New 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-((4-substitutedureido)-4-phenylpiperidin-1-yl)propyl)piperidine derivatives having selective NK3 receptor antagonist activity, useful for treating e.g. central nervous system disorders

摘要

The invention concerns compounds of formula (I) in racemic or optically pure form, methods for obtaining them and pharmaceutical compositions containing same. Said compounds are selective NK3 receptor antagonists.